Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,988 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

NCT00048555

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Research site Birmingham, Alabama, United States
  • Research site Tucson, Arizona, United States
  • Research site Los Angeles, California, United States
  • Research site Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Malaria Treatment With Injectable ArteSunate

NCT01828333

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • Centre de Santé CECO Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé la Famille Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Hôpital Général de Référence IME Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Centre de Santé Ngeba Kisantu, Bas-Congo Province, Democratic Republic of the Congo
View Trial Details
Completed

Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

NCT00462332

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Universita Degli Studi di Bari Bari, Italy
  • Universita Cattolica del Sacro Cuore - Campobasso Campobasso, Italy
  • Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy
View all 23 locations
View Trial Details
Completed

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

NCT00738829

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tyrol, Austria
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria
  • Krankenhaus der Elisabethinen Linz GmbH Linz, Austria
View Trial Details

Related conditions